Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620).
Journal: Breast cancer research and treatment
Published: September 22, 2022
A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer.
Journal: Cancer chemotherapy and pharmacology
Published: January 07, 2022
Management of breast cancer brain metastases is moving forward, but new options are still needed.
Journal: Oncology (Williston Park, N.Y.)
Published: August 22, 2014
Showing 1-3 of 3
Last Updated: 09/26/2026